COLISTIN (Colomycin® and Promixin ®)

Clinical Indication

Nebulised for cystic fibrosis

Comments

Historic patients only. Must be prescribed by brand as the brands are not interchangeable.

Date of classification

July 2006

Review date

October 2020

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.